Table 3 HCPs’ Knowledge regarding TB in Kereyu pastoralist district, Ethiopia
Variables | Frequency (n = 108) | Percent (%) | ||
|---|---|---|---|---|
Cause of TB | ||||
Mycobacterium tuberculosis | 106 | 98.1 | ||
Mycobacterium pneumonia | 1 | 0.9 | ||
Mycobacterium contagiosum | 1 | 0.9 | ||
Organs most affected | ||||
Lung | 97 | 89.8 | ||
Bones | 8 | 7.4 | ||
Kidney | 2 | 1.9 | ||
Abdominal organs | 1 | 0.9 | ||
Routes of TB transmission | ||||
Droplets from coughing and sneezing of a person with active TB | 94 | 87 | ||
Sharing cups | 13 | 12 | ||
Handshaking | 1 | 0.9 | ||
Factors for the spread of TB | ||||
Household contact | 98 | 90.7 | ||
Overcrowding | 6 | 5.6 | ||
Humidity | 10 | 9.3 | ||
Poor nutrition | 6 | 5.6 | ||
People at high risk of developing TB | Yes | Percent% | No | Percent % |
HIV positive | 94 | 87 | 14 | 13 |
People in contact with TB patient | 46 | 42.6 | 62 | 57.4 |
People with chronic disease | 28 | 25.9 | 80 | 74.1 |
Pregnant women | 6 | 5.6 | 102 | 94.4 |
Infectious type of TB | ||||
Active pulmonary TB | 100 | 92.6 | 7.4 | |
TB in other organs/body parts | 8 | 7.4 | 1.9 | |
Symptoms suspicious for TB | ||||
Cough for more than three weeks | 74 | 68.5 | 34 | 31.5 |
Fever | 87 | 80.6 | 21 | 19.4 |
Haemoptysis | 94 | 87 | 14 | 13 |
Night sweating | 83 | 76.9 | 25 | 23.1 |
Loss of appetite | 78 | 72.2 | 30 | 27.8 |
Loss of weight | 77 | 71.3 | 31 | 28.7 |
General weakness | 71 | 65.7 | 337 | 34.3 |
Chest pain | 82 | 75.9 | 26 | 24.1 |
Diagnosis of Active PTB | ||||
Two or three positive smear tests | 95 | 88.0 | ||
One positive smear and positive X-ray | 13 | 12.0 | ||
Relapse TB | ||||
Completed treatment. Cured and returned with positive smear | 84 | 77.8 | ||
Under treatment & sputum remains positive after 5 months | 10 | 9.3 | ||
Interrupted treatment for 3 months and returned with positive smear | 14 | 13 | ||
Duration of active PTB treatment | ||||
6 months | 102 | 94.4 | ||
9 months | 3 | 2.8 | ||
2–5 months | 1 | 0.9 | ||
Do not know | 1 | 0.9 | ||
Duration of intensive TB treatment phase | ||||
2 months | 94 | 87.0 | ||
6 months | 11 | 10.2 | ||
9 months | 1 | 0.9 | ||
12 months | 2 | 1.9 | ||
MDR-TB | ||||
When the bacilli is resistant to all currently available drugs of TB | 32 | 29.6 | ||
When the bacilli is resistant to at least isoniazid and pyrazinamide | 49 | 45.4 | ||
When the bacilli is very aggressive and you need at least 8 to 12 months of treatment | 23 | 21.3 | ||
Others | 4 | 3.7 | ||